These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3741914)

  • 21. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
    Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
    Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans.
    Morrow JD; Awad JA; Oates JA; Roberts LJ
    J Invest Dermatol; 1992 May; 98(5):812-5. PubMed ID: 1373750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Niacin skin flushing in schizophrenic and depressed patients and healthy controls.
    Bosveld-van Haandel L; Knegtering R; Kluiter H; van den Bosch RJ
    Psychiatry Res; 2006 Aug; 143(2-3):303-6. PubMed ID: 16837062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia.
    Smesny S; Klemm S; Stockebrand M; Grunwald S; Gerhard UJ; Rosburg T; Sauer H; Blanz B
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):79-85. PubMed ID: 17904833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1.
    Lai E; De Lepeleire I; Crumley TM; Liu F; Wenning LA; Michiels N; Vets E; O'Neill G; Wagner JA; Gottesdiener K
    Clin Pharmacol Ther; 2007 Jun; 81(6):849-57. PubMed ID: 17392721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker.
    Wang DD; Hu XW; Jiang J; Sun LY; Qing Y; Yang XH; Gao Y; Cui GP; Li MH; Wang PK; Zhang J; Zhuang Y; Li ZZ; Li J; Guan LL; Zhang TH; Wang JJ; Ji F; Wan CL
    Schizophr Res; 2021 Apr; 230():53-60. PubMed ID: 33677199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schizophrenia: a biochemical disorder?
    Horrobin DF
    Biomedicine; 1980 May; 32(2):54-5. PubMed ID: 7388116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRPV1 channels are involved in niacin-induced cutaneous vasodilation in mice.
    Clifton HL; Inceoglu B; Ma L; Zheng J; Schaefer S
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):184-91. PubMed ID: 25387247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin.
    Shah SH; Vankar GK; Peet M; Ramchand CN
    Schizophr Res; 2000 Jun; 43(2-3):163-4. PubMed ID: 11001591
    [No Abstract]   [Full Text] [Related]  

  • 30. The niacin response biomarker as a schizophrenia endophenotype: A status update.
    Messamore E
    Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():95-97. PubMed ID: 28688777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia.
    Puri BK; Hirsch SR; Easton T; Richardson AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):49-52. PubMed ID: 11853118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Niacin flushing and schizophrenia.
    Vaddadi KS
    Med Hypotheses; 1981 May; 7(5):599-600. PubMed ID: 7278724
    [No Abstract]   [Full Text] [Related]  

  • 33. Niacin skin test response in dyslexia.
    Cyhlarova E; Montgomery P; Ross MA; Richardson AJ
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):123-8. PubMed ID: 17890071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation.
    Cefali EA; Simmons PD; Stanek EJ; Shamp TR
    Int J Clin Pharmacol Ther; 2006 Dec; 44(12):633-40. PubMed ID: 17190373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder.
    Smesny S; Baur K; Rudolph N; Nenadic I; Sauer H
    J Affect Disord; 2010 Aug; 124(3):335-40. PubMed ID: 20116108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potential objective marker in first-episode schizophrenia based on abnormal niacin response.
    Hu Y; Xu L; Gan R; Wu G; Tang X; Wei Y; Cui H; Hui L; Tang Y; Li C; Chen T; Wan C; Wang J; Zhang T
    Schizophr Res; 2022 May; 243():405-412. PubMed ID: 34187733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The niacin test in schizophrenia].
    Weterle R; Rybakowski J
    Psychiatr Pol; 1990; 24(2):116-20. PubMed ID: 2084715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of PLA2G4A and PTGS2 gene polymorphisms, and red blood cell PUFAs deficit on niacin skin flush response in schizophrenia patients.
    Nadalin S; Giacometti J; Jonovska S; Tomljanović D; Buretić-Tomljanović A
    Prostaglandins Leukot Essent Fatty Acids; 2013 Feb; 88(2):185-90. PubMed ID: 23219238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-distribution of sensory gating and impaired niacin flush response in the parents of schizophrenics.
    Waldo MC
    Schizophr Res; 1999 Nov; 40(1):49-53. PubMed ID: 10541007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin reduces cutaneous flushing after administration of an optimized extended-release niacin formulation.
    Cefali EA; Simmons PD; Stanek EJ; McGovern ME; Kissling CJ
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):78-88. PubMed ID: 17323787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.